We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Stock Moves -1.77%: What You Should Know
Read MoreHide Full Article
In the latest close session, Tenet Healthcare (THC - Free Report) was down 1.77% at $193.26. This change was narrower than the S&P 500's 2.06% loss on the day. Meanwhile, the Dow lost 1.76%, and the Nasdaq, a tech-heavy index, lost 2.39%.
The stock of hospital operator has fallen by 1.57% in the past month, lagging the Medical sector's loss of 0.88% and the S&P 500's gain of 1.63%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on February 11, 2026. The company is predicted to post an EPS of $4.05, indicating a 17.73% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $5.45 billion, showing a 7.44% escalation compared to the year-ago quarter.
THC's full-year Zacks Consensus Estimates are calling for earnings of $16.14 per share and revenue of $21.27 billion. These results would represent year-over-year changes of +35.86% and 0%, respectively.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.21% lower. Right now, Tenet Healthcare possesses a Zacks Rank of #4 (Sell).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 11.86. Its industry sports an average Forward P/E of 8.5, so one might conclude that Tenet Healthcare is trading at a premium comparatively.
Investors should also note that THC has a PEG ratio of 0.84 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Hospital was holding an average PEG ratio of 0.84 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 216, positioning it in the bottom 12% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Stock Moves -1.77%: What You Should Know
In the latest close session, Tenet Healthcare (THC - Free Report) was down 1.77% at $193.26. This change was narrower than the S&P 500's 2.06% loss on the day. Meanwhile, the Dow lost 1.76%, and the Nasdaq, a tech-heavy index, lost 2.39%.
The stock of hospital operator has fallen by 1.57% in the past month, lagging the Medical sector's loss of 0.88% and the S&P 500's gain of 1.63%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on February 11, 2026. The company is predicted to post an EPS of $4.05, indicating a 17.73% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $5.45 billion, showing a 7.44% escalation compared to the year-ago quarter.
THC's full-year Zacks Consensus Estimates are calling for earnings of $16.14 per share and revenue of $21.27 billion. These results would represent year-over-year changes of +35.86% and 0%, respectively.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.21% lower. Right now, Tenet Healthcare possesses a Zacks Rank of #4 (Sell).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 11.86. Its industry sports an average Forward P/E of 8.5, so one might conclude that Tenet Healthcare is trading at a premium comparatively.
Investors should also note that THC has a PEG ratio of 0.84 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Hospital was holding an average PEG ratio of 0.84 at yesterday's closing price.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 216, positioning it in the bottom 12% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.